Nu-Med Plus (NUMD) Income from Continuing Operations (2012 - 2025)
Nu-Med Plus (NUMD) posted Income from Continuing Operations of 12618.0 for Q4 2025, down 5.45% sequentially from 11966.0 in Q3 2025, and down 19.55% YoY from 15683.35 in Q4 2024.
Nu-Med Plus (NUMD) Income from Continuing Operations (2012 - 2025) Analysis & Trends
Nu-Med Plus has reported Income from Continuing Operations for 14 years, with the latest figure at 12618.0 in Q4 2025.
- Quarterly Income from Continuing Operations fell 19.55% year-over-year to 12618.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 56182.0 (up 17.8% YoY) and the FY2025 annual result came in at 56182.0, up 17.8% from the prior year.
- Income from Continuing Operations retreated to 12618.0 in Q4 2025 per NUMD's latest filing, from 11966.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 42606.0 in Q4 2022 and troughed at 2185374.0 in Q4 2021.
- A 5-year average of 164784.9 and a median of 23073.0 in 2023 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2021 and 2022: Income from Continuing Operations plunged 330.45% in 2021, then soared 101.95% in 2022.
- Over 5 years, Income from Continuing Operations stood at 2185374.0 in 2021, then jumped by 101.95% to 42606.0 in 2022, then sank by 232.84% to 56596.0 in 2023, then surged by 81.35% to 10555.0 in 2024, then decreased by 19.55% to 12618.0 in 2025.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 12618.0, 11966.0, and 11665.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.31 Bn | 193.71 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.55 Bn | 126.08 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 119.91 Bn | 110.69 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.06 Bn | 73.52 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.45 Bn | 48.20 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.16 Bn | 22.68 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | 19,670.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -12,618.00 |
| Sep 30, 2025 | -11,966.00 |
| Jun 30, 2025 | -11,665.00 |
| Mar 31, 2025 | -19,933.00 |
| Dec 31, 2024 | -10,555.00 |
| Sep 30, 2024 | -18,677.00 |
| Jun 30, 2024 | -17,287.00 |
| Mar 31, 2024 | -21,826.00 |
| Dec 31, 2023 | -56,596.00 |
| Sep 30, 2023 | -16,406.00 |
| Jun 30, 2023 | -24,320.00 |
| Mar 31, 2023 | -28,204.00 |
| Dec 31, 2022 | 42,606.00 |
| Sep 30, 2022 | -58,050.00 |
| Jun 30, 2022 | -58,070.00 |
| Mar 31, 2022 | -59,653.00 |
| Dec 31, 2021 | -2.19 Mn |
| Sep 30, 2021 | -118,366.00 |
| Jun 30, 2021 | -251,990.00 |
| Mar 31, 2021 | -356,748.00 |